RecruitingNCT07155148

Argentine Registry of Crohn's Disease and Ulcerative Colitis


Sponsor

Grupo Argentino de Enfermedad de Crohn y Colitis Ulcerosa

Enrollment

4,250 participants

Start Date

Jul 14, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

RADECCU is a strictly observational IBD registry in Argentina. The registry is open to all practicing gastroenterologist in the country grouped within the Argentinean Crohn's and Ulcerative Colitis Group (GADECCU). The registry will include outcomes of routine clinical practice of patients with IBD including the pediatric and adult population.


Eligibility

Plain Language Summary

Simplified for easier understanding

This registry in Argentina is collecting long-term data on patients with inflammatory bowel disease (IBD) — including Crohn's disease and ulcerative colitis — to improve understanding of how these conditions progress and respond to treatment in real-world settings. **You may be eligible if...** - You have been diagnosed with Crohn's disease or ulcerative colitis based on established clinical, endoscopic, lab, and imaging criteria - You consent to having your data included **You may NOT be eligible if...** - Your IBD diagnosis is suspected but not confirmed - Your records on treatment and follow-up are incomplete Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERobservational study

Observational registry without clinical interventions


Locations(1)

Hospital Privado Universitario de Cordoba

Córdoba, Córdoba Province, Argentina

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07155148


Related Trials